Global challenges are impacting Indian stocks. West Asian tensions and rising US inflation create headwinds. Tech sector shifts also affect...

Indian pharma stocks are outperforming the market, offering strong returns to investors. This resilience is driven by robust domestic deman...

Wipro's significant Rs 15,000 crore share buyback has commenced. Eligible shareholders can tender shares at Rs 250, a substantial premium t...

Investors have a final opportunity to tender shares in buyback offers from Zydus Lifesciences, Dhanuka Agritech, and CyberTech Systems and ...

CMR Green Technologies shares fell sharply from their post-listing highs after debuting at a 43% premium to the IPO price. While analysts r...

Wipro's Rs 15,000 crore share buyback opens on Thursday, offering shareholders an opportunity to tender their shares at Rs 250 apiece, a 38...

Indian markets experienced a volatile session, closing higher amidst mixed signals. Bulls are defending the 23,000 level in Nifty, but unce...

A promoter entity of Ajanta Pharma sold shares worth over Rs 1,024 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya B...

IT major Wipro's Rs 15,000-crore share buyback offer will commence on June 11 and conclude on June 17, 2026. Small shareholders can tender ...

Wipro shares dropped significantly on Monday. This decline follows the company's share buyback record date. Investors who bought shares for...

Zepto has come under the ED's scanner as part of its probe into Parimatch. This and more in today's ETtech Top 5.

Wipro shares fell sharply on Friday after turning ex-record date for its Rs 15,000 crore buyback, despite broader market gains in the early...

Investors must purchase Wipro shares by today, June 4th, to be eligible for the company's Rs 15,000 crore share buyback, as Friday, June 5t...

Alkem Laboratories has launched semaglutide in single-shot pre-filled syringes in India. This makes treatment more accessible and affordabl...

Natco Pharma shares plunged after the company reported a steep fall in fourth-quarter profit, revenue and EBITDA. Weak operating margins an...

Zydus Lifesciences increased its share buyback price to Rs 1,260 per share while reducing the repurchase size to 87.3 lakh shares. The tota...

Investors must purchase Zydus Lifesciences shares by Wednesday, May 27, to be eligible for the Rs 1,100 crore buyback, as the record date i...